Vial Label: 8.4% Sodium Bicarbonate Injection, USP, 50mEq/50 mL (1 mEq/mL), Rx only, Hospira, Inc., Lake Forest, IL 60045, USA, NDC 0409-6637-24. Case NDC: 00409-6637-14.
Published August 27, 2025 · Recall initiated: August 4, 2025
Summary
FDA records drug Class II recall D-0591-2025, published August 27, 2025 and initiated August 4, 2025. Recalling firm: PFIZER INC; Status: Ongoing; Reported quantity: 15,750 vials; Lot: Lot #: LH2671, Exp. 11/30/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility.
What to do
Voluntary: Firm initiated · Letter
Get an email if SODIUM BICARBONATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- SODIUM BICARBONATE
- Manufacturer
- PFIZER INC
- Distributor
- U.S. Nationwide
- Lot
- Lot #: LH2671, Exp. 11/30/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDA4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10 mL (0.5 mEq/mL), For Intravenous Use Only, 10 mL Single DoseSeptember 17, 2025
- FDAVial Label: Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL), Rx only, Distributed by Hospira, Inc., LakeAugust 27, 2025
- FDASensodyne PRONAMEL (Potassium nitrate 5%, Sodium fluoride 0.25%) Active SHIELD Toothpaste for Sensitive Teeth,August 27, 2025
- FDA8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1 mEq/mL), 25 x 50 mL Single Dose Vials per carton, ForApril 2, 2025
- FDA8.4 % Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), Lifeshield, Glass ABBOJECT Unit of UseJanuary 24, 2024
- FDA8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1mEq/mL), a) 20x50 mL Single Dose Vials (Vial NDCNovember 29, 2023
Questions about this recall
Was Vial Label: 8.4% Sodium Bicarbonate Injection, USP, 50mEq/50 mL (1 mEq/mL), Rx only, Hospira, Inc., Lake Forest, IL 60045, USA, NDC 0409-6637-24. Case NDC: 00409-6637-14. recalled?
Yes. FDA published recall D-0591-2025 on August 27, 2025. Reported hazard: Lack of Assurance of Sterility.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: SODIUM BICARBONATE.